Manish Raturi: Does Patient Type Matter in Massive Blood Transfusion?
Manish Raturi, Additional Professor in Transfusion Medicine at AIIMS Nagpur, Maharashtra, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Global Journal of Transfusion Medicine, adding:
”Our research ‘Compliance and Outcome Analysis of Massive Blood Transfusion Protocol (MBTP) Activation in Trauma vs Nontrauma Patients,’ is now published in the Global Journal of Transfusion Medicine.
We found that trauma patients had significantly higher compliance with MBTP, and received more packed red blood cells, and demonstrated better survival compared with non-trauma massively bleeding patients, where protocol adherence was more variable.
These findings underscore the need for standardized MBTP implementation and continuous monitoring across both trauma and nontrauma settings to improve patient outcomes in any tertiary care hospital.”
Title: Compliance and Outcome Analysis of Massive Blood Transfusion Protocol Activation in Trauma vs Nontrauma Patients: Insights from a Tertiary Care Hospital in India
Authors: Pranjul Sharmal, Manish Raturi, Mukta Singh
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering